ABG Sundal Collier Upgrades Swedish Orphan Biovitrum to Buy, Boosts PT

MT Newswires · 4d ago
08:38 AM EST, 01/08/2026 (MT Newswires) -- ABG Sundal Collier on Thursday upgraded biopharmaceutical company Swedish Orphan Biovitrum (SOBI.ST) to buy from hold and increased its price target to 450 kronor from 290 kronor. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)